Belldegrun Arie

Director at CHEM RX CORP · on record since Jan 31, 2006
Director at Cougar Biotechnology, Inc. · on record since Apr 13, 2006
10% owner at Cougar Biotechnology, Inc. · on record since Apr 13, 2006
Director at Talon Therapeutics, Inc. · on record since Dec 18, 2006
10% owner at LB PHARMACEUTICALS INC · on record since Sep 16, 2025
Director at Arno Therapeutics, Inc · on record since Jun 13, 2008
Director at Ginkgo Bioworks Holdings, Inc. · on record since Sep 20, 2021
Director at CAPRICOR THERAPEUTICS, INC. · on record since Sep 28, 2009
Director at Kite Pharma, Inc. · on record since Jun 19, 2014
Chairman, President and CEO at Kite Pharma, Inc. · on record since Jun 19, 2014
10% owner at Kite Pharma, Inc. · on record since Jun 19, 2014
Director at Allogene Therapeutics, Inc. · on record since Oct 17, 2018
10% owner at Allogene Therapeutics, Inc. · on record since Oct 17, 2018
Director at UroGen Pharma Ltd. · on record since Mar 28, 2019
Director at Kronos Bio, Inc. · on record since Oct 16, 2020
10% owner at Kronos Bio, Inc. · on record since Oct 8, 2020

Insider trading activity of Belldegrun Arie

Transactions on record: 241; since Nov 15, 2005

Open-market buys: 26; $21.1M

Open-market sells: 2; $4.9M

Companies traded: 10; last filing Jun 24, 2026

Figures computed from official regulatory filings — .

Companies where Belldegrun Arie has traded

UroGen Pharma Ltd.18 tx · $1.9M · Jun 24, 2026
33 tx · $25.9M · Feb 4, 2026
20 tx · $6.1M · Jun 20, 2025
8 tx · Jun 14, 2024
34 tx · $599M · Oct 5, 2017
67 tx · $2M · Aug 17, 2016
3 tx · May 12, 2011
47 tx · $44.8M · Jul 7, 2009
4 tx · Feb 26, 2009
7 tx · $31.7K · Jan 31, 2006

Track record of Belldegrun Arie

Statistical track record

Free account

Open-market buys: 42

Last buy: May 16, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Belldegrun Arie

Co-insiders of Belldegrun Arie

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
UroGen Pharma Ltd.Listing on record	Jun 24, 2026	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	929,913	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	263,033	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 27, 2025	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-20,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	Other	-2,765,314	0.57 USD	$1.6M		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	Other	-679,575	0.57 USD	$387.4K		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 28, 2025	AwardD (derivative)	1,307,927	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 28, 2025	Award	369,957	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 8, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 26, 2024	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	571,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	432,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	Exercise	105,263	—	n/a (No price was disclosed in the filing)		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	ExerciseD (derivative)	-105,263	—	n/a (No price was disclosed in the filing)		SEC
Allogene Therapeutics, Inc.Listing on record	May 20, 2024	Award	344,828	2.90 USD	$1M		SEC
Allogene Therapeutics, Inc.Listing on record	May 20, 2024	Buy	1,724,137	2.90 USD	$5M	conv 81Unusual sizeFirst in 12mo	SEC
Allogene Therapeutics, Inc.Listing on record	Jan 31, 2024	Award	211,973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 31, 2024	AwardD (derivative)	749,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Sep 8, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 26, 2023	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 21, 2023	AwardD (derivative)	105,263	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
UroGen Pharma Ltd.Listing on record	Jun 24, 2026	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	929,913	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	263,033	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 27, 2025	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-20,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	Other	-2,765,314	0.57 USD	$1.6M		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	Other	-679,575	0.57 USD	$387.4K		SEC
Kronos Bio, Inc.Listing unverified	Jun 20, 2025	OtherD (derivative)	-34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 28, 2025	AwardD (derivative)	1,307,927	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 28, 2025	Award	369,957	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 8, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 26, 2024	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	571,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	432,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	Exercise	105,263	—	n/a (No price was disclosed in the filing)		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 14, 2024	ExerciseD (derivative)	-105,263	—	n/a (No price was disclosed in the filing)		SEC
Allogene Therapeutics, Inc.Listing on record	May 20, 2024	Award	344,828	2.90 USD	$1M		SEC
Allogene Therapeutics, Inc.Listing on record	May 20, 2024	Buy	1,724,137	2.90 USD	$5M	conv 81Unusual sizeFirst in 12mo	SEC
Allogene Therapeutics, Inc.Listing on record	Jan 31, 2024	Award	211,973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Allogene Therapeutics, Inc.Listing on record	Jan 31, 2024	AwardD (derivative)	749,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Sep 8, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 26, 2023	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Jun 21, 2023	AwardD (derivative)	105,263	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC